STOCK TITAN

Felicia Williams Joins NeoGenomics Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management

NeoGenomics (NASDAQ: NEO) has appointed Felicia Williams to its Board of Directors, effective November 1, 2024. Williams, former interim CFO of Macy's and Fellow for CEO Action for Racial Equality, brings over 35 years of experience in finance, accounting, audit, and enterprise risk management from multinational corporations including Macy's, The Coca-Cola Company, and Bristol Myers-Squibb. She will serve on the Audit and Finance and Nominating and Corporate Governance Committees. Williams currently serves on the Board of Directors of Paycom and Anywhere Real Estate.

NeoGenomics (NASDAQ: NEO) ha nominato Felicia Williams nel suo Consiglio di Amministrazione, a partire dal 1° novembre 2024. Williams, ex CFO ad interim di Macy's e Fellow per l'Iniziativa CEO per l'Uguaglianza Razziale, porta con sé oltre 35 anni di esperienza in finanza, contabilità, audit e gestione del rischio d'impresa in importanti multinazionali tra cui Macy's, The Coca-Cola Company e Bristol Myers-Squibb. Servirà nei Comitati di Audit e Finanza e di Nominazione e Governance Aziendale. Attualmente, Williams è anche membro del Consiglio di Amministrazione di Paycom e Anywhere Real Estate.

NeoGenomics (NASDAQ: NEO) ha nombrado a Felicia Williams en su Junta Directiva, a partir del 1 de noviembre de 2024. Williams, ex CFO interina de Macy's y Fellow de la Iniciativa CEO por la Igualdad Racial, aporta más de 35 años de experiencia en finanzas, contabilidad, auditoría y gestión de riesgos empresariales en corporaciones multinacionales como Macy's, The Coca-Cola Company y Bristol Myers-Squibb. Formará parte de los Comités de Auditoría y Finanzas y de Nominación y Gobernanza Corporativa. Actualmente, Williams también forma parte de la Junta Directiva de Paycom y Anywhere Real Estate.

NeoGenomics (NASDAQ: NEO)가 Felicia Williams를 이사회에 임명했습니다. 임기는 2024년 11월 1일부터 시작됩니다. Williams는 Macy's의 전 임시 CFO이자 인종 평등을 위한 CEO 액션 프로그램의 펠로우로서, Macy's, The Coca-Cola Company 및 Bristol Myers-Squibb를 포함한 다국적 기업에서 재무, 회계, 감사 및 기업 위험 관리 분야에서 35년 이상의 경력을 가져옵니다. 그녀는 감사 및 재무, 지명 및 기업 거버넌스 위원회에서 활동할 예정입니다. 현재 Williams는 Paycom 및 Anywhere Real Estate의 이사회에서도 활동하고 있습니다.

NeoGenomics (NASDAQ: NEO) a nommé Felicia Williams à son Conseil d'Administration, à compter du 1er novembre 2024. Williams, ancienne CFO intérimaire de Macy's et Fellow pour l'Action des PDG pour l'Égalité Raciale, apporte plus de 35 ans d'expérience en finance, comptabilité, audit et gestion des risques d'entreprise provenant de multinationales telles que Macy's, The Coca-Cola Company et Bristol Myers-Squibb. Elle siégera aux Comités d'Audit et de Finances ainsi qu'au Comité de Nominations et de Gouvernance d'Entreprise. Williams siège actuellement au Conseil d'Administration de Paycom et Anywhere Real Estate.

NeoGenomics (NASDAQ: NEO) hat Felicia Williams mit Wirkung zum 1. November 2024 in seinen Vorstand berufen. Williams, die ehemalige interimistische CFO von Macy's und Fellow der CEO-Aktion für Rassengleichheit, bringt über 35 Jahre Erfahrung in den Bereichen Finanzen, Buchhaltung, Prüfung und Enterprise Risk Management aus multinationalen Unternehmen wie Macy's, The Coca-Cola Company und Bristol Myers-Squibb mit. Sie wird in den Prüfungsausschüssen für Finanzen sowie im Nominierungs- und Governance-Ausschuss tätig sein. Momentan sitzt Williams außerdem im Vorstand von Paycom und Anywhere Real Estate.

Positive
  • Addition of board member with extensive financial expertise and multinational corporate experience
  • Strengthening of audit and governance oversight with experienced financial executive
Negative
  • None.

FORT MYERS, Fla.--(BUSINESS WIRE)-- NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced the appointment of Felicia Williams to its Board of Directors.

“We are fortunate to welcome Felicia Williams to our board of directors, bringing her experience across the spectrum of finance, accounting, audit, and enterprise risk management to NeoGenomics,” said Lynn Tetrault, Chairwoman of the Board of NeoGenomics. “We look forward to working together to support the company and improve patient care.”

The Board has elected Felicia Williams to join the Board as an independent director effective November 1, 2024. Felicia, former interim CFO of Macy’s Inc. and Fellow for CEO Action for Racial Equality, will be a member of the Audit and Finance and Nominating and Corporate Governance Committees. Felicia joins a strong, independent board with world-class talent and unique and differentiated skillsets.

Felicia Williams Biography

Felicia Williams has had a multi-dimensional business career across the spectrum of finance, including Treasury, enterprise risk management, accounting, and audit. Felicia has more than 35 years of experience leading multinational corporations such as Macy’s, Inc., The Coca-Cola Company and Bristol Myers-Squibb. Felicia is also a member of the Board of Directors of Paycom and Anywhere Real Estate.

About NeoGenomics, Inc.

NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus for physicians to help them diagnose and treat cancer. The Company's Advanced Diagnostic Division also serves pharmaceutical clients in clinical trials and drug development.

Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories for full-service sample processing in Fort Myers, Florida; Aliso Viejo and Carlsbad, California; Research Triangle Park, North Carolina; and Houston, Texas; and a CAP accredited full-service, sample-processing laboratory in Cambridge, United Kingdom. NeoGenomics also has several, small, non-processing laboratory locations across the United States for providing analysis services. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and a pharmaceutical firm in Europe.

Forward-Looking Statements

This press release includes forward-looking statements. Each forward-looking statement contained in this press release is subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the Company's ability to identify and implement appropriate financial and operational initiatives to improve performance, to identify and recruit executive candidates, to continue gaining new customers, offer new types of tests, integrate its acquisitions and otherwise implement its business plan, and the risks identified under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 20, 2024 as well as other information previously filed with the SEC. The forward-looking statements in this press release speak only as of the date of this document, and we undertake no obligation to update or revise any of these statements.

Investor Contact

Kendra Sweeney

kendra.sweeney@neogenomics.com

Media Contact

Andrea Sampson

asampson@sampsonprgroup.com

Source: NeoGenomics, Inc.

FAQ

When will Felicia Williams join NeoGenomics (NEO) Board of Directors?

Felicia Williams will join NeoGenomics' Board of Directors effective November 1, 2024.

What committees will Felicia Williams serve on at NeoGenomics (NEO)?

Felicia Williams will serve on the Audit and Finance Committee and the Nominating and Corporate Governance Committee.

What is Felicia Williams' background before joining NeoGenomics (NEO) board?

Felicia Williams has over 35 years of experience in finance, including roles at Macy's (former interim CFO), The Coca-Cola Company, and Bristol Myers-Squibb.

NeoGenomics, Inc.

NASDAQ:NEO

NEO Rankings

NEO Latest News

NEO Stock Data

2.05B
126.69M
1.28%
99.7%
3.31%
Diagnostics & Research
Services-testing Laboratories
Link
United States of America
FORT MYERS